Research in cancer cell biology is leading to the development of novel therapeutic strategies, such as targeted therapies and immunotherapies. Targeted therapies aim to disrupt specific molecular pathways critical for cancer cell survival. Immunotherapies, including checkpoint inhibitors and CAR T-cell therapy, leverage the immune system to recognize and destroy cancer cells. These advancements are transforming cancer treatment by providing more effective and personalized options.
